EVO PAYMENTS INC-CLASS A (EVOP)

US26927E1047 - Common Stock

33.99  +0.13 (+0.38%)

After market: 33.98 -0.01 (-0.03%)

Fundamental Rating

3

Taking everything into account, EVOP scores 3 out of 10 in our fundamental rating. EVOP was compared to 102 industry peers in the Financial Services industry. There are concerns on the financial health of EVOP while its profitability can be described as average. EVOP is quite expensive at the moment. It does show a decent growth rate.



5

1. Profitability

1.1 Basic Checks

In the past year EVOP has reported negative net income.
In the past year EVOP had a positive cash flow from operations.
EVOP had negative earnings in each of the past 5 years.
Each year in the past 5 years EVOP had a positive operating cash flow.

1.2 Ratios

The profitability ratios for EVOP are negative, so there is not much use analyzing them.
EVOP has a Return On Invested Capital of 3.67%. This is in the better half of the industry: EVOP outperforms 65.63% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EVOP is significantly above the industry average of 7.93%.
The 3 year average ROIC (23.91%) for EVOP is well above the current ROIC(3.67%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 3.67%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)23.91%
ROIC(5y)N/A

1.3 Margins

With a decent Operating Margin value of 12.33%, EVOP is doing good in the industry, outperforming 61.46% of the companies in the same industry.
EVOP's Operating Margin has improved in the last couple of years.
EVOP has a Gross Margin of 83.54%. This is amongst the best in the industry. EVOP outperforms 94.79% of its industry peers.
In the last couple of years the Gross Margin of EVOP has grown nicely.
Industry RankSector Rank
OM 12.33%
PM (TTM) N/A
GM 83.54%
OM growth 3Y26.78%
OM growth 5Y6.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.39%
GM growth 5Y4.38%

3

2. Health

2.1 Basic Checks

EVOP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for EVOP has been increased compared to 1 year ago.
EVOP has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, EVOP has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.14, we must say that EVOP is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.14, EVOP is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
EVOP has a debt to FCF ratio of 6.22. This is a slightly negative value and a sign of low solvency as EVOP would need 6.22 years to pay back of all of its debts.
EVOP's Debt to FCF ratio of 6.22 is in line compared to the rest of the industry. EVOP outperforms 54.17% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.22
Altman-Z 0.14
ROIC/WACC0.5
WACC7.27%

2.3 Liquidity

A Current Ratio of 1.11 indicates that EVOP should not have too much problems paying its short term obligations.
EVOP's Current ratio of 1.11 is in line compared to the rest of the industry. EVOP outperforms 43.75% of its industry peers.
A Quick Ratio of 1.10 indicates that EVOP should not have too much problems paying its short term obligations.
EVOP has a Quick ratio (1.10) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.1

4

3. Growth

3.1 Past

EVOP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -289.17%.
Looking at the last year, EVOP shows a quite strong growth in Revenue. The Revenue has grown by 9.35% in the last year.
EVOP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.47% yearly.
EPS 1Y (TTM)-289.17%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-442.51%
Revenue 1Y (TTM)9.35%
Revenue growth 3Y3.79%
Revenue growth 5Y1.47%
Revenue growth Q2Q4.98%

3.2 Future

Based on estimates for the next years, EVOP will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.23% on average per year.
EVOP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.43% yearly.
EPS Next Y11.11%
EPS Next 2Y13.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.83%
Revenue Next 2Y12.43%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

EVOP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 25.63 indicates a quite expensive valuation of EVOP.
EVOP's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.92, EVOP is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 25.63

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EVOP is valued a bit cheaper than 66.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EVOP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 15.94
EV/EBITDA 12.75

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as EVOP's earnings are expected to grow with 13.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

EVOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EVO PAYMENTS INC-CLASS A

NASDAQ:EVOP (3/23/2023, 8:00:02 PM)

After market: 33.98 -0.01 (-0.03%)

33.99

+0.13 (+0.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.65B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.63
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 12.33%
PM (TTM) N/A
GM 83.54%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.11
Quick Ratio 1.1
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-289.17%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y11.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.35%
Revenue growth 3Y3.79%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y